Literature DB >> 13125197

Aerosols of pancreatic dornase in bronchopulmonary disease.

A SALOMON, J A HERCHFUS, M S SEGAL.   

Abstract

Entities:  

Keywords:  AEROSOLS/therapeutic use; BRONCHI/diseases; LUNGS/diseases; NUCLEASES

Mesh：

Substances：

Year:  1954        PMID： 13125197

Source DB:  PubMed          Journal:  Ann Allergy        ISSN： 0003-4738


× No keyword cloud information.
  5 in total

1.  Reduction of Sputum Viscosity.

Authors: 
Journal:  Br Med J       Date:  1962-03-31

Review 2.  The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.

Authors:  M S Zach
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

3.  rhDNase in cystic fibrosis.

Authors:  S P Range; A J Knox
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

4.  Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Authors:  S Shak; D J Capon; R Hellmiss; S A Marsters; C L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Targeting of dornase alpha therapy in adult cystic fibrosis.

Authors:  M J Ledson; Z Wahbi; R P Convery; C Cowperthwaite; D P Heaf; M J Walshaw
Journal:  J R Soc Med       Date:  1998-07       Impact factor: 5.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.